Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06363734
What this trial is testing

Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial

Who this might be right for
Non-small Cell Lung CancerEGFR Activating MutationCell Cycle Deregulation+1 more
Tianjin Medical University Cancer Institute and Hospital 32
Not applicableActive Not RecruitingNCT06141564
What this trial is testing

Detect and Expunge Concealed Tumors of the Liver

Who this might be right for
Liver Cancer
Johns Hopkins University 360
Testing effectiveness (Phase 2)UnknownNCT04524299
What this trial is testing

Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 160
Not applicableWithdrawnNCT01300299
What this trial is testing

STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
University of Louisville
Not applicableActive Not RecruitingNCT07391137
What this trial is testing

CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBC

Who this might be right for
Recurrence Free SurvivalBladder Cancer Recurrence
S. Andrea Hospital 250
Testing effectiveness (Phase 2)Study completedNCT00092001
What this trial is testing

Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 111
Testing effectiveness (Phase 2)Ended earlyNCT00484601
What this trial is testing

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Who this might be right for
Refractory Nasopharyngeal Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT01730612
What this trial is testing

ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA

Who this might be right for
HER2 Negative Breast Carcinoma Expressing CEA
Nantes University Hospital 23
Not applicableUnknownNCT05576519
What this trial is testing

Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian Carcinoma
Sohag University 50
Testing effectiveness (Phase 2)UnknownNCT06182800
What this trial is testing

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

Who this might be right for
Non-small Cell Lung Cancer
The First Affiliated Hospital of Xinxiang Medical College 35
Testing effectiveness (Phase 2)Study completedNCT05253807
What this trial is testing

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Incyte Corporation 8
Testing effectiveness (Phase 2)Study completedNCT00368992
What this trial is testing

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more
National Cancer Institute (NCI) 110
Not applicableLooking for participantsNCT04641936
What this trial is testing

Urine Omics Predicting IO Therapy Responses in mUC Patients

Who this might be right for
Metastatic Urothelial Carcinoma
National Taiwan University Hospital 600
Not applicableStudy completedNCT05022511
What this trial is testing

Three Birds With One Stone

Who this might be right for
Uterine Cervical CancerUterine Cervix CancerUterine Cervical Neoplasm+5 more
University of Aarhus 27,099
Testing effectiveness (Phase 2)Study completedNCT00004211
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 17
Early research (Phase 1)Study completedNCT02199171
What this trial is testing

Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
FIGO Stage IIC-IV Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma
University of California, Irvine 30
Large-scale testing (Phase 3)Study completedNCT00982111
What this trial is testing

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 633
Testing effectiveness (Phase 2)Study completedNCT00002637
What this trial is testing

Biological Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT04553939
What this trial is testing

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

Who this might be right for
Urothelial CarcinomaBladder Cancer
Henan Cancer Hospital 50
Not applicableStudy completedNCT03725475
What this trial is testing

Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

Who this might be right for
Non-small-cell Lung Cancer (NSCLC)
AstraZeneca 3,111
Next Page